[Clinical evaluation of hydroxy-ethylated starch (preparation HAES)].
Hydroxy-ethylated starch (HAES-Fresenius) has been evaluated clinically at the Department of Anesthesiology and Intensive Care, Medical Academy in Warsaw. This plasma substitute is used in several countries as plasma substitute similar to dextran but of better properties. Results of our studies have shown, that HAES is worth its opinion. It is quite good plasma substitute of favourable effect on tissue perfusion. The above features together with a wide therapeutical margin and the lack of any effect on blood coagulation place HAES over dextran plasma substitutes. This preparation should have wider use in Poland.
Mayzner-Zawadzka
E
E
Katedry Anestezjologii i Intensywnej Terapii AM, Warszawie.
Kraska
A
A
Kamiński
B
B
D005069:Evaluation Studies as Topic; D006801:Humans; D006895:Hydroxyethyl Starch Derivatives / Q000627:therapeutic use*
D006895:Hydroxyethyl Starch Derivatives